Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

· näytä muistiinpanot
01:59:30
Podcasts
RSS
Link

TIETOJA TÄSTÄ JAKSOSTA

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

  • Introduction (0:00)
  • Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
  • Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
  • CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
  • Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
  • Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

Lääketiede
Koulutus
Terveys ja kunto
Lääketiede
Tiede
Englanti
Yhdysvallat
KäytäAPI:tä tämän jakson hakemiseenJSON:ssä

TÄSSÄ EPISODISSA

Muokkaa näitä tunnisteita

NÄYTÄ HUOMAUTUKSIA 🔗

00:00:00Introduction
00:07:05Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles
00:26:21Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel
00:43:12Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar
01:08:33CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles
01:24:44Other Approved and Emerging Novel Therapies for FL — Dr Patel
01:41:34Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar

TRANSKRIPTIO 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

HAE EDELLISIÄ EPISODEJA

Hae kanavan Oncology Today with Dr Neil Love vanhoja jaksoja.
Upota tämä hakupalkki verkkosivustollesi

MUITA jaksoja TÄSSÄ PODCASTISSA

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and …
01:58:22
JAA
TALLENNA
Chronic Lymphocytic Leukemia — Microlearning Activity 2

Chronic Lymphocytic Leukemia — Microlearning Activity 2

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00) Role of…
00:27:51
JAA
TALLENNA
Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her mid 50s with BRCA1-mutated recurrent ovarian cancer receives mirvetuximab soravtansine — Ursula Ma…
00:12:17
JAA
TALLENNA
Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor the…
00:24:32
JAA
TALLENNA
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HA…
00:24:03
JAA
TALLENNA
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Dr. Neil Love:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

SUOSITUKSET
Käytä API:a tämän episodin hakemiseen